The Li+/Na+ exchange in hypertension

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Seniplicini, Andrea ^a,b   Sartori, Michelangelo ^a   Ceolotto, Giulio ^a   Calò, Lorenzo A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Diabetes; Hypertension; IDDM; Li+ NA + countertransport; LNE; Nephropathy; NHE; NIDDM; Review

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CANRENONE; CAPTOPRIL; CELL MARKER; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; KETANSERIN; LAXATIVE; LITHIUM; LITHIUM ION; METFORMIN; METOPROLOL; ORAL CONTRACEPTIVE AGENT; SODIUM ION; ANTIPORTER; SODIUM;

BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATION EXCHANGE; CELL MEMBRANE; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FAMILY HISTORY; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOKALEMIA; INSULIN RESISTANCE; KIDNEY DISEASE; LIPID BLOOD LEVEL; MATERNAL HYPERTENSION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREGNANCY; PROTON SODIUM EXCHANGE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM ABSORPTION; SODIUM TRANSPORT; STOICHIOMETRY; BLOOD; ERYTHROCYTE MEMBRANE; METABOLISM;

ANTIPORTERS; ERYTHROCYTE MEMBRANE; HUMANS; HYPERTENSION; LITHIUM; SODIUM;

EID: 3242671852     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (191)

1. Baidessarini R. J: Drugs and the treatment of psychiatric disorders. In: The pharmacological basis of the therapeutics. Eds: Goodman Gilman A. Goodman L. S. Gilman A. Mc Millan Publ. Comp. 391 (1980)
2. Mendels J, & A. Frazer: Intracellular lithium concentration and clinical response. Towards a membrane theory of depression. J. Psychiatr. Res. 10, 9-19 (1973)
3. Haas M, J. Schooler, & D.C. Tosteson: Coupling of lithium to sodium transport in human red cells. Nature 258, 425-7 (1975)
4. Duhm J, F. Eisenried, B.F. Becker, & W. Greil: Studies on the lithium transport across the red cell membrane. Li uphill transport by the Na-dependent Li countertransportsystem of human erythrocytes. Pflugers Arch Eur. J. Physiol. 364, 147-55 (1976)
5. Duhm J, & B. D. Becker: Studies on the lithium transport across the red cell membrane. III Factors contributing to the intraindividual variability of the in vitro Li+ distribution across the human red cell membrane. Pflugers Arch. Eur. J. Physiol. 368, 203-8 (1977)
6. Pandey G. N, B. Sarkadi, M. Haas, R. B. Gunn, J. M. Davis, & D. C. Tosteson: Lithium transport pathways in human red blood cells. J. Gen. Physiol. 72, 233-47 (1978)
7. Sarkadi B, J. K. Alifimoff, R. B. Gunn, & D. C. Tosteson: Kinetics and stoichiometry of Na-dependent Li transport in human red cells. J. Gen. Physiol. 72, 249-65 (1978)
8. Ehrlich BE, & J. M. Diamond: Lithium fluxes in human erythrocytes. Am. J. Physiol. 237, C102-10 (1979)
9. Canessa M, N. Adragna, H. S. Solomon, T. M. Connolly, & D. C. Tosteson: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N. Engl. J. Med, 302, 772-6 (1980)
10. Canessa M, I. Bize, H. Solomon, N. Adragna, D. C. Tosteson, G. Dagher, R. Garay, & P. Meyer: Na countertransport and cotransport in human red cells: function, dysfunction, and genes in essential hypertension. Clin. Exp. Hypertension 3, 783-95 (1981)
11. Hannaert P.A, & R. P. Garay: A kinetic analysis of Na-Li countertransport in human red blood cells. J. Gen. Physiol. 87, 353-68 (1986)
12. + countertransport across the erythrocyte membrane. Clin. Chem. 43, 1090-2 (1997)
13. Canessa M: Kinetic properties of Na/H exchange and Li/Na, Na/Na, and Na/Li exchanges of human red cells. Methods. Enzymol. 173, 176-91 (1989)
14. Ibsen KK, H. A. Jensen, J. O. Wieth, & J. Funder: Essential hypertension: sodium-lithium countertransport in erythrocytes from patients and from children having one hypertensive parent. Hypertension, 4, 703-9 (1982)
15. Duhm J, & B. O. Gobel: Sodium-lithium exchange and sodium-potassium cotransport in human erythrocytes. Part 1: Evaluation of a simple uptake test to assess the activity of the two transport systems. Hypertension 4, 468-76 (1982)
16. Hentschel WM, L. L. Wu, G. O. Tobin, H. B. Anstall, J. B. Smith, R. R. Williams, & K. O. Ash: Erythrocyte cation transport activities as a function of cell age. Clin. Chim. Acta 157, 33-43 (1986)
17. Carr S, T. H. Thomas, & R. Wilkinson: Sodium-lithium countertransport activity and its sensitivity to inhibitors with erythrocyte ageing in man. Clin. Chim. Acta, 178, 51-8 (1988)
18. Smith JB, K. O. Ash, S. C. Hunt, W. M. Hentschel, W. Sprowell, M. M. Dadone, & R. R. Williams: Three red cell sodium transport systems in hypertensive and normotensive Utah adults. Hypertension 6, 159-66 (1984)
19. Turner ST, M. Johnson, E. Boerwinkle, E. Richelson, H. F. Taswell, & C. F. Sing: Sodium-lithium countertransport and blood pressure in healthy blood donors. Hypertension 7, 955-62 (1985)
20. Boerwinkle E, S. T. Turner, R. Weinshilboum, M. Johnson, E. Richelson, & C. F. Sing: Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population. Genet. Epidemiol. 3, 365-78 (1986)
21. Hasstedt SJ, L. L. Wu, K. O. Ash, H. Kuida, & R. R. Williams: Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major-locus inheritance. Am. J. Hum. Genet. 43, 14-22 (1988)
22. Mozzato MG, A. Semplicini, S. Zamboni, V. Urbani, M. Marzola, L. Mazzucato, G. B. Ambrosio, & A. C. Pessina: II controtrasporto Li/Na eritrocitario e le variabili ad esso correlate in un campione randomizzato di popolazione. Cardiologia 34, 347-51 (1989)
23. Rutherford PA, T. H. Thomas, & R. Wilkinson: Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium. Clin. Sci. 79, 365-9 (1990)
24. Siebers RW, & T. J. Maling: Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects. J. Cardiovasc. Pharmacol. 16, S59-61 (1990)
25. Laurenzi M, & M. Trevisan: Sodium-lithium countertransport and blood pressure: The Gubbio population study. Hypertension 13, 408-15 (1989)
26. Turner ST, W. H. Weidman, V. V. Michels, T. J. Reed, C. L. Ormson, T. Fuller, & C. F. Sing: Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension 13, 378-91 (1989)
27. Weder AB, & N. J. Schork: Mixture analysis of erythrocyte lithium-sodium countertran sport and blood pressure. Hypertension 13, 145-50 (1989)
28. Weder AB, N. J. Schork, L. Krause, & S. Julius: Red blood cell lithium-sodium countertransport in the Tecumseh blood pressure study. Hypertension 17, 652-60 (1991)
29. Laurenzi M, & M. Trevisan: Erythrocyte sodium-lithium countertransport levels in an entire population: findings of the Gubbio study. J. Hypertension, 5 (suppl.5), S273-4 (1987)
30. Williams RR, S. C. Hunt, H. Kuida, J. B. Smith, & K. O. Ash: Sodium-lithium countertransport in erythrocytes of hypertension prone families in Utah. Am. J. Epidemiol. 118, 338-44 (1983)
31. Trevisan M, D. Ostrow, R. S. Cooper, C. Sempos, & J. Stamler: Sex and race differences in sodium-lithium countertransport and red cell sodium concentration. Am. J. Epidemiol. 120, 537-41 (1984)
32. Trevisan, M., D. Ostrow, R. S. Cooper, K. Liu, S. Sparks, A. Okonek, E. Stevens, J. Marquardt, & J. Stamler: Abnormal red blood cell ion transport and hypertension. The People's Gas Company study. Hypertension 5, 363-7 (1983)
33. Arumanayagam M, D. MacDonald, & R. Swaminathan: Differences in erythrocyte cation (sodium) transport between Chinese and non Chinese males. Clin. Exp. Hypertension 9, 719-39 (1987)
34. Worley RJ, W. M. Hentschel, C. Cormier, S. G. Nutting, K. Zelenkov, J. B. Smith, K. O. Ash, & R. R. Williams: Increased sodium-lithium countertransport in erythrocytes of pregnant women. N. Engl. J. Med 307, 412-6 (1982)
35. Canessa M: The polymorphism of red cell Na and K transport in essential hypertension: findings, controversies, and prespectives. In: Erythrocyte membranes 3: recent clinical and experimental advances. EDS: Kruckeberg WC Eaton JW Aster J Brewer GJ AR Liss Inc., New York, pp 293-8 (1984)
36. Brugnara C, R. Corrocher, L. Foroni, M. Steinmayr, F. Bonfanti, & G. De Sandre: Lithium-sodium countertransport in erythrocytes of normal and hypertensive subjects. Relationship with age and plasma renin activity. Hypertension 5, 529-34 (1983)
37. Kagamimori S, Y. Naruse, M. Takata, & T. Fujita: Familial aggregation of red blood cell cation transport systems in Japanese families. Am. J. Epidemiol. 122, 386-90 (1985)
38. Motulsky AG, W Burke, PR Billings, & RH Ward: Hypertension and the genetics of red cell membrane abnormalities. In: Molecular approaches to human poligenic disease 130 Ciba Foundation Symposium. Wiley Chichester 150-165 (1987)
39. Weder AB, N. J. Schork, & S. Julius: Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Hypertension 17, 977-81 (1991)
40. Kammerer CM, L. A. Cox, M. C. Mahaney, J. Rogers, & R. E. Shade: Sodium-lithium countertransport activity is linked to chromosome 5 in baboons. Hypertension 37, 398-402 (2001)
41. Orlov SN, Z. Pausova, F. Gossard, D. Gaudet, J. Tremblay, T. Kotchen, A. Cowley, P. Larochelle, & P. Hamet: Sibling resemblance of erythrocyte ion transporters in French-Canadian sibling-pairs affected with essential hypertension. J Hypertens. 17, 1859-65 (1999)
42. Hardman TC, S. W. Dubrey, R. D. Leslie, & A. F. Lant: Erythrocyte sodium-lithium countertransport activity in non-nephropathic diabetic twins. Diabetes Care. 19, 32-8 (1996)
43. Cirillo M, M. Laurenzi, W. Panarelli, M. Trevisan, & J. Stamler: Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Population Study Research Group. Hypertension. 33, 887-93 (1999)
44. Weder AB, M. C. Delgado, X. Zhu, L. Gleiberman, D. Kan, & A. Chakravarti: Linkage of Erythrocyte Sodium-Litium countertransport activity and chromosome 15q26. Hypertenions. 40, 395 (2002)
45. Canali M, L. Borghi, E. Sani, A. Curti, A. Montanari, A. Novarini, & A. Borghetti: Increased erythrocyte lithium-sodium countertransport in essential hypertension: its relationship to family history of hypertension. Clin. Sci. 61, 13s-15s (1981)
46. Cusi D, C. Barlassina, M. Ferrandi, P. Lupi, P. Ferrari, & G. Bianchi: Familial aggregation of cation transport abnormalities and essential hypertension. Clin. Exp. Hypertension 3, 871-84 (1981)
47. Adragna NC, M. Canessa, H. Solomon, E. Slater, & D. C. Tosteson: Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension. Hypertension 4, 795-804 (1982)
48. Clegg G, D. B. Morgan, & C. Davidson: The heterogeneity of essential hypertension. Relation between lithium efflux and sodium content of erythrocytes and a family history of hypertension. Lancet 2, 891-4 (1982)
49. Woods JW, R. J. Falk, A. W. Pittman, P. J. Klemmer, B. S. Watson, & K. Namboodiri: Increased red-cell sodium-lithium countertransport in normotensive sons of hypertensive parents. N. Engl. J. Med. 306, 593-5 (1982)
50. Cooper R, D. LeGrady, S. Nanas, M. Trevisan, M. Mansour, P. Histand, D. Ostrow, & J. Stamler: Increased sodium-lithium countertransport in college students with elevated blood pressure. JAMA 249, 1030-4 (1983)
51. Fujita T, H. Noda, K. Ando, & Y. Sato: Peripheral resistance and red cell Li-Na countertransport in borderline hypertensives. Life Sci. 32, 1621-7 (1983)
52. Levy R, E. Paran, A. Keynan, & A. Livne: Essential hypertension: improved differentiation by the temperature dependence of Li efflux in erythrocytes. Hypertension 5, 821-7 (1983)
53. Canessa M, A. Spalvins, N. Adragna, & B. Falkner: Red cell sodium countertransport and cotransport in normotensive and hypertensive blacks. Hypertension, 6, 344-51 (1984)
54. Weder AB, B. A. Torretti, & S. Julius: Racial differences in erythrocyte cation transport. Hypertension 6, 115-23 (1984)
55. Corrocher R, M. Steinmayr, O. Ruzzenente, C. Brugnara, L. Bertinato, M. Mazzi, C. Furri, F. Bonfanti, & G. De Sandre: Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci. 36, 649-55 (1985)
56. Hunt SC, R. R. Williams, J. B. Smith, K. O. Ash, & H. Kuida: The relationship of lithium-potassium cotransport and the passive lithium leak to hypertension in Utah subjects. Clin. Exp. Hypertension 7, 1409-26 (1985)
57. + countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after and hypertensive treatment. Klin. Wochenschr. 64, 1101-5 (1986)
58. + countertransport and blood viscosity in arterial hypertension. Res. Exp. Med. (Berl) 186, 71-7 (1986)
59. Hunt SC, R. R. Williams, J. B. Smith, & K. O. Ash: Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects. Hypertension 8, 30-6 (1986)
60. Morgan DB, A. D. Stewart, & C. Davidson: Relations between erythrocyte lithium efflux, blood pressure and family histories of hypertension and cardiovascular disease: studies in a factory workforce and hypertension clinic. J. Hypertension 4, 09-15 (1986)
61. Gless KH, U. Sutterlin, K. Schaz, V. Schutz, & W. Hunstein: Intracellular sodium concentration and transport in red cells in essential hypertension, hyperthyroidism, pregnancy and hypokalemia. Clin. Physiol. Biochem. 4, 199-209 (1986)
62. McDonald A, M. Trevisan, R. Cooper, R. Stamler, F. Gosch, D. Ostrow, & J. Stamler: Epidemiological studies of sodium transport and hypertension. Hypertension 10, 142-7 (1987)
63. Turner ST, E. Boerwinkle, M. Johnson, E. Richelson, & C. F. Sing: Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients, Hypertension. 9, 24-34 (1987)
64. +-K+ cotransport, and the hemodynamics of hypertension. Hypertension 9, 459-66 (1987)
65. Yap L, A. Arrazola, F. Soria, & J. Diez: Is there increased cardiovascular risk in essential hypertensive patients with abnormal kinetics of red blood cell sodium-lithium countertransport? J. Hypertension 7, 667-73 (1989)
66. + exchange in patients with essential hypertension. Am. J. Hypertension 2, 903-8 (1989)
67. Weinberger MH, J. B. Smith, N. S. Fineberg, & F. C. Luft: Red-cell sodium-lithium countertransport and fractional excretion of lithium in normal and hypertensive humans. Hypertension 13, 206-12 (1989)
68. Hunt SC, S. H. Stephenson, P. N. Hopkins, & R. R. Williams: Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 17, 969-76 (1991)
69. Turner ST, & V. V. Michels: Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension 18, 183-90 (1991)
70. Andronico G, M. T. Mangano, E. Nardi, G. Mule, G. Piazza, & G. Cerasola: Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy. J Hypertens 11, 1097-101 (1993)
71. + binding and phospholipid composition in erythrocyte membranes of white hypertensive and normotensive individuals: a nuclear magnetic resonance investigation. Hypertension 27, 456-64 (1996)
72. Muriana FJ, J. Villar, & V. Ruiz-Gutierrez: Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport. J Hypertens 14, 443-6 (1996)
73. Herlitz H, K. Landin, & B. Widgren: Relationship between sodium-lithium counter-transport and insulin sensitivity in mild hypertension. J Intern Med 239, 235-40 (1996)
74. + countertransport activity in essential hypertensive patients. Eur J Clin Invest 26, 64-70 (1996)
75. Andronico G, L. Ferrara, M. Mangano, G. Mule, & G. Cerasola: Insulin, sodium-lithium countertransport, and microalbuminuria in hypertensive patients. Hypertension 31, 110-3 (1998)
76. Brearley CJ, A. J. Wood, J. K. Aronson, & D. G. Grahame-Smith: Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension. J Hypertens 11, 147-53 (1993)
77. Zerbini G, G. Ceolotto, C. Gaboury, L. Mos, A. C. Pessina, M. Canessa, & A. Semplicini: Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects. Hypertension 25, 986-93 (1995)
78. + countertransport rate is elevated in essential hypertension. J Hypertens 19, 1263-9 (2001)
79. + countertransport in essential hypertension. J. Hypertension 6, 931-7 (1988)
80. Mongeau JG, P. Mauran, G. Poirot, & A. Davignon: Longitudinal study of various transport abnormalities as an idex of severity in children and adolescentes suffering from essential hypertension. J. Hypertension 8, 657-62 (1990)
81. McDonald AM, A. R. Dyer, K. Liu, R. Stamler, F. C. Gosch, R. Grimm, R. Berman, & J. Stamler: Sodium, lithium-countertransport and blood pressure control by nutritional intervention in 'mild' hypertension. J. Hypertension 6, 283-91 (1988)
82. Cooper R, M. Trevisan, L. Van Horn, E. Larbi, K. Liu, S. Nanas, H. Ueshima, C. Sempos, D. Ostrow, & J. Stamler: Effect of dietary sodium reduction on red blood cell sodium concentration and sodium-lithium countertransport Hypertension 6, 731-5 (1984)
83. Canessa M, J. Redgrave, C. Laski, & G. H. Williams: Does sodium intake modify red cell Na transporters in normal and hypertensive subjects. Am. J. Hypertension 2, 515-23 (1989)
84. Hunt SC, S. Stephenson, P. N. Hopkins, S. J. Hasstedt, & R. R. Williams: A prospective study of sodium-lithium countertransport and hypertension in Utah. Hypertension 17, 1-7 (1991)
85. Strazzullo P, A. Siani, F. P. Cappuccio, M. Trevisan, E. Ragone, L. Russo, R. Iacone, & E. Farinaro: Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study. Hypertension 31, 1284-9 (1998)
86. Laurenzi M, M. Cirillo, W. Panarelli, M. Trevisan, R. Stamler, A. R. Dyer, & J. Stamler: Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio Population Study. Circulation 95, 581-7 (1997)
87. Thomas TH, P. A. Rutherford, K. Vareesangthip, R. Wilkinson, & I. C. West: Erythrocyte membrane thiol proteins associated with changes in the kinetics of Na/Li countertransport: a possible molecular explanation of changes in disease. Eur J Clin Invest 28, 259-65 (1998)
88. Mead P, R. Wilkinson, & T. H. Thomas: Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension. Hypertension 34, 1275-80 (1999)
89. Watkins SL, I. C. West, R. Wilkinson, & T. H. Thomas: Abnormal thiol reactivity of tropomyosin in essential hypertension and its association with abnormal sodium-lithium countertransport kinetics. J Hypertens. 19, 485-93 (2001)
90. Corry DB, M. Tuck, A. S. Brickman, N. Yanagawa, & D. B. Lee: Sodium transport in red blood cells from dialyzed uremic patients. Kidney Int. 29, 1197-202 (1986)
91. DeSanto NG, M. Trevisan, S. DeColle, M. DiMuro, F. DeChiara, M. Latte, A. Franzese, R. Iacono, G. Capasso, & G. Capodicasa: Intraerythrocytic cation metabolism in children with uremia undergoing hemodialysis. J. Lab. Clin. Med. 110, 231-6 (1987)
92. + countertransport activity in primary aldosteronism. Eur J Clin Invest. 24, 794-8 (1994)
93. Petrov VV, C G. Arabidze, D. O. Levitsky, A. O. Eliseev, & P. J. Lijnen: Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension. Methods Find Exp Clin Pharmacol. 16, 153-7 (1994)
94. Weder AB, & B. A. Torretti: Erythrocyte lithium transport changes induced by deoxycorticosterone acetate treatment in pigs. Hypertension 7, 541-6 (1985)
95. Woods JW, J. C. Parker, & B. S. Watson: Perturbation of sodium-lithium countertransport in red cells. N. Engl. J. Med. 308, 1258-61 (1983)
96. Trevisan M, N. DeSanto, M. Laurenzi, M. DiMuro, F. DeChiara, M. Latte, A. Franzese, R. Iacone, G. Capodicasa, & C. Giordano: Intracellular ion metabolism in erythrocytes and uraemia: the effect of different dialysis treatments. Clin. Sci. 71, 545-52 (1986)
97. Smith JB, K. O. Ash, M. C. Gregory, W. L. Sprowell, W. M. Hentschel, & R. R. Williams: Hemodialysis does not affect erythrocyte sodium-lithium countertransport. Clin. Chim. Acta 143, 275-9 (1984)
98. Corrocher R, L. Bertinato, C. Brugnara, L. M. Guadagnini, A. Bassi, F, Bonfanti, S. Losi, & G. Stopelli: Placental hormones and elevation of erytrocyte sodium-lithium countertransport in pregnancy. Clin. Exp. Hypertension B5, 9-25 (1986)
99. Beuckelmann D, & E. Erdmann: Exogenous factors influencing the human erythrocyte sodium-lithium countertransport system. Eur. J. Clin. Invest. 14, 392-7 (1984)
100. Diamond JM, S. S. Matsuyama, K. Meier, & L. F. Jarvik: Elevation of erythrocyte countertransport rates in Alzheimer's dementia, N. Engl. J. Med. 309, 1061-2 (1983)
101. Brent GA, M. Canessa, & R. G. Dluhy: Reversible alteration of red cell lithium-sodium countertransport in patients with thyroid disease. J. Clin. Endocrinol. Metab. 68, 322-8 (1989)
102. Mattioli M, P. Delva, C. Lechi, P. Minuz, A. Lechi, & L. A. Scuro: Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome. J. Endocrinol. Invest. 7, 61-3 (1984)
103. Calo L, M. Felice, S. Cantaro, G. Ceolotto, A. Monari, A. Antonello, & A. Semplicini: Inhibition of furosemide-sensitive cation transport and activation of sodium-lithium exchange by endogenous circulating factor(s) in Bartter's and Gitelman's syndromes. J Hypertens. 15(12 Pt 1), 1407-13 (1997)
104. Sutterlin U, K. H. Gless, K. Schaz, M. Hufner, V. Schutz, & W. Hunstein: Peripheral effects of thyroid hormones: alteration of intracellular Na-concentration, ouabain-sensitive Na-transport, and Na-Li countertransport in human red blood cells. Klin. Wochenschr. 62, 598-601 (1984)
105. Bianchi G, G. Vezzoli, D. Cusi, T. Cova, A. Elli, L. Soldati, G. Tripodi, M. Surian, E. Ottaviano, P. Rigatti, & S. Ortolani: Abnormal red cell calcium pump in patients with idiopathic hypercalciuria. N. Engl. J. Med. 319, 897-901 (1988)
106. Semplicini A, M. Mozzato, E. Rigon, O. Parolin, B. Sama', S. Padovan, P. Degan, A. Peserico, & A. C. Pessina: Red blood cell sodium and potassium fluxes in psoriatic patients. Eur. J. Clin. Invest. 18, 47-51 (1988)
107. Coca A, R. P. Garay, M. T. Aguilera, A. De la Sierra, & A. Urbano-Marquez: Disturbances of transmembranous sodium transport systems induced by ethanol in human erythrocytes. Am. J. Hypertension 2, 784-7 (1989)
108. Gobel BO, M. Ruppert, C. Ressel, & K. O. Stumpe: Erythrocyte cation transport and blood pressure in chronic alcoholics. J. Hypertension 5 (suppl.5), S295-6 (1987)
109. Miilunpalo S, R. Saarinen, & J. Marniemi: Red-cell sodium-potassium pump and sodium-lithium countertransport in human obesity. Re-evaluation of the methods and association in a finnish population. Int. J. Obesity 9, 313-21 (1985)
110. Bunker CH, R. R. Wing, D. J. Becker, & L. H. Kuller: Sodium-lithium countertransport activity is decreased after weight loss in healthy obese men. Metabolism 42, 1052-8 (1993)
111. Adragna NC, J. L. Chang, M. C. Morey, & R. S. Williams: Effect of exercise on cation transport in human red cells, Hypertension 7, 132-9 (1985)
112. Duhm J, & J. Behr: Role of exogenous factors in alterations of red cell Na-Li exchange and Na-K cotransport in essential hypertension, primary hyperaldosteronism, and hypokaliemia. Scand. J. Clin. Lab. Invest. 46, 82-95 (1986)
113. Carr SJ, T. H. Thomas, M. F. Laker, & R. Wilkinson: Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension? J. Hypertension 8, 139-46 (1990)
114. Hajem S, T. Moreau, P. Hannaert, J. Lellouch, G. Orssaud, G. Huel, J. R. Claude, & R. P., Garay: Erythrocyte cation transport systems and plasma lipids in a general male population. J. Hypertension 8, 891-6 (1990)
115. Dowd A, T. H. Thomas, & R. Wilkinson: Increased human erythrocyte sodium-lithium countertransport in hyperlipidaemic patients may indicate increased membrane lipid fluidity. Eur J Clin Invest. 23, 102-7 (1993)
116. Messner H, W. Kleophas, D. Hein, A. Gries, & J. Kobberling: Sodium lithium countertransport is acutely influenced by heparin-induced extracorporal LDL precipitation. Eur. J. Clin. Invest. 21, 215-8 (1991)
117. Engelmann B, J. Duhm, U. M. Schonthier, & S. Streich: of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipids in hyperlipidemia. Atherosclerosis 99, 151-63 (1993)
118. + countertransport: in vivo and in vitro evidence. J Membr Biol. 133, 99-106 (1993)
119. Weder AB, C. Serr, B. A. Torretti, D. R., Bassett, & A. Zweifler: Effects of lovastatin treatment on red blood cell and platelet cation transport. Hypertension 17, 203-9 (1991)
120. Levy R, D. Hevroni, Z. I. Cabantchik, & A. Livne: Lii-Nao countertransport and Li leak in erythrocytes are differentially affected by membrane enrichment with cholesteryl hemisuccinate. Biochim. Biophys. Acta 854, 325-8 (1986)
121. Pagnan A, R. Corrocher, G. B. Ambrosio, S. Ferrari, P. Guarini, D. Piccolo, A. Opportune, A. Bassi, O. Olivieri, & G. Baggio: Effects of an olive-oil-rich diet on erythrocyte membrane lipid composition and cation transport systems. Clin. Sci. 76, 87-93 (1989)
122. Murray GE, & J. Patrick: Effect of dietary fat on sodium transport and sodium-lithium counter-transport in rat erythrocytes and thymocytes. J. Nutr. 116, 1390-4 (1986)
123. Semplicini A, E. Casiglia, M. Marzola, G. Ceolotto, R. Businaro, O. Olivieri, P. Guarini, R. Corrocher, C. Martines, & C. Dal Palu': Effects of linoleic acid supplementation on blood pressure and kinetics of red cell Na transport: the Piove di Sacco Study. J. Hypertension 9, S310-1 (1991)
124. Winocour PH, T. H. Thomas, L. Brown, M. F. Laker, R. Wilkinson, & K. G. Alberti: Serum triglyceride and insulin levels are associated with erythrocyte sodium-lithium counter-transport activity in normoglycaemic individuals. Clin Chim Acta. 208, 193-203 (1992)
125. Ferrannini E, G. Buzzigoli, R. Bonadonna, M.A. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, & A. Bevilacqua: Insulin resistance in hypertension. N. Engl. J. Med.. 317, 350-7 (1987)
126. Strazzullo P, F. P. Cappuccio, M. Trevisan, L. lacoviello, R. Iacone, G. Barba, A. De Leo, E. Farinaro, & M. Mancini: Red blood cell sodium-lithium countertransport, blood pressure, and uric acid metabolism in untreated healthy men. Am. J. Hypertension 2, 634-6 (1989)
127. Strazzullo P, F. P. Cappuccio, G. Barba, M. Trevisan, C. Ciacci, R. Iacone, & L. Russo: Altered renal tubular function in men with high erythrocyte sodium-lithium countertransport. J Hypertension 7 (Suppl. 6), S154-5 (1989)
128. Reaven G: Role of insulin resistance in human disease. Diabetes 37, 1595-607 (1988)
129. Weder AB: Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N. Engl. J. Med.. 314, 198-201 (1986)
130. Strazzullo P, F. P. Cappuccio, M. Trevisan, L. Iacoviello, R. Iacone, F. Jossa, N. Giorgione, E. Farinaro, & M. Mancini: Erythrocyte sodium/lithium countertransport and renal ithium clearance in a random sample of untreated middle-aged men. Clin. Sci. 77, 337-42 (1989)
131. Maling TJ, & R. W. Siebers: Sodium-lithium countertransport is not a marker of proximal tubular sodium clearance. J. Cardiovasc. Pharmacol. 16, S50-1 (1990)
132. Nosadini R, A. Semplicini, P. Fioretto, L. Lusiani, R. Trevisan, V. Donadon, G. Zanette, G. L. Nicolosi, V. Dall'Aglio, D. Zanuttini, & G. C. Viberti: Sodium-lithium countertransport and cardio-renal abnormalities in essential hypertension. Hypertension 18, 191-8 (1991)
133. Lijnen P, P. Hespel, R. Fagard, J. Staessen, W. Goossens, W. Lissens, & A. Amery: Erythrocyte and leucocyte sodium and potassium transport systems during long-term diuretic administration in men. J. Hypertension, 6, 639-45 (1988)
134. Niutta E, D. Cusi, R. Colombo, M. Pellizzoni, C. Cesana, C. Barlassina, L. Soldati, & G. Bianchi: Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin. J. Hypertension 8 (suppl 4), S53-8 (1990)
135. Sechi LA, R. Tedde, L. Cassisa, A. Marigliano, F. Uneddu, A. Melis, & A. Pala: Effects of ketanserin on transmembrane sodium transport in erythrocytes. J. Cardiovasc. Pharmacol. 15, 269-75 (1990)
136. Semplicini A, M. G. Mozzato, E. Rigon, O. Parolin, B. Sama', P. Degan, A. C. Pessina, & C. Dal Palu': Does essential hypertension with low Na-K cotransport and/or high Li-Na countertransport represent a clinical entity. J. Hypertension 4 (Suppl.5), s219 (1986)
137. Redgrave J, M. Canessa, R. Gleason, N. K. Hollenberg, & G. H. Williams: Red blood cell Li-Na countertransport in non modulating essential hypertension. Hypertension 13, II 721-6 (1989)
138. Sanchez RA, M. I. Gimenez, M. Migliorini, C. Giannone, A. J. Ramirez, & A. B. Weder: Erythrocyte sodium-lithium countertransport in non-modulating offspring and essential hypertensive individuals: response to enalapril. Hypertension 30, 99-105 (1997)
139. + transport and atrial natriuretic peptide. J Nephrol. 15, 489-96 (2002)
140. + exchange, cardiac anatomy and function in insulin dependent diabetes. Eur. J. Clin. Invest. 22, 254-9 (1992)
141. Macphail S, T. H. Thomas, R. Wilkinson, J. M. Davison, & W. Dunlop: Erythrocyte sodium lithium countertransport in normal and hypertensive pregnancy: relation to haemodynamic changes. Br. J. Obstet. Gynaecol. 100, 673-8 (1993)
142. Rutherford PA, T.H. Thomas, S. MacPhail, & R. Wilkinson: Sodium-lithium countertransport kinetics in normal and hypertensive human pregnancy. Eur. J. Clin. Invest. 22, 50-4 (1992)
143. Ferrari P, & P. Weidmann: Insulin, insulin sensitivity and hypertension. J. Hypertension 8, 491-50 (1990)
144. Natali A, D. Santoro, C. Palombo, M. Cerri, S. Ghione, & E. Ferrannini: Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17, 170-8 (1991)
145. + exchange decreases the affinity of sodium sites. Kidney Int. 46, 365-375 (1994)
146. Canessa M: Erythrocyte sodium-lithium countertransport: another link between essential hypertension and diabetes. Curr. Opin. Nephrol. Hypertens. 3, 511-7 (1994)
147. Rutherford PA, T. H. Thomas, T. Hardman, A. F. Lant, & R. Wilkinson: Sodium-lithium countertransport activity is not affected by short-term insulin exposure in vivo or in a physiologic medium in vitro. Metabolism 42, 1087-9 (1993)
148. + countertransport by physiological levels of insulin in vitro. J Hypertens. 9, 713-7 (1991)
149. + countertransport in non-insulin-dependent diabetes mellitus. J Hum Hypertens. 9, 685-6 (1995)
150. + countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment. Metabolism 46, 1316-23 (1997)
151. Trevisan M, O. Vaccaro, M. Laurenzi, F. De Chiara, M. Di Muro, & R. Iacone, A. Franzese: Hypertension, non-insulin-dependent diabetes, and intracellular sodium metabolism. Hypertension 11, 264-8 (1988)
152. Trevisan, M., M. Cirillo, & M. Laurenzi: Sodium lithium countertransport and glucose metabolism. J. Hypertension 8 (suppl. 3), s124-5 (1990)
153. Johnson BA, J. R. Sowers, P. C. Zemel, F. C. Luft, & M. B. Zemel: Increased sodium-lithium countertransport in black non-insulin-dependent diabetic hypertensives. Am. J. Hypertension 3, 563-5 (1990)
154. Fujita J, K. Tsuda, M. Seno, H. Obayashi, I. Fukui, & Y. Seino: Elevated erythrocyte sodium-lithium countertransport activity correlates with increased intracellular sodium and free calcium-ion concentration in type 2 diabetes. Diabet Med. 13, 53-8 (1996)
155. Fujita J, K. Tsuda, M. Seno, H. Obayashi, I. Fukui, & Y. Seino: Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 17, 977-82 (1994)
156. Sampson MJ, E. Denver, W. J. Foyle, D. Dawson, J. Pinkney, & J. S. Yudkin: Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM. Diabetologia 38, 454-60 (1995)
157. Pinkney JH, W. J. Foyle, A. E. Denver, V. Mohamed-Ali, S. McKinlay, & J. S. Yudkin: The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 38, 356-62 (1995)
158. Semplicini A, M. G. Mozzato, B. Sama', R. Nosadini, P. Fioretto, R. Trevisan, A. C. Pessina, G. Crepaldi, & C. Dal Palu': Na/H and Li/Na exchange in red blood cells of normotensive and hypertensive patients with insulin dependent diabetes mellitus (IDDM). Am. J. Hypertension 2, 174-7 (1989)
159. Nosadini R, G. C. Viberti, A. Doria, P. Fioretto, R. Trevisan, A. Avogaro, A. Semplicini, V. Donadon, & G. Zanette: Increased Na/H countertransport activity is associated with cardiac hypetrophy and insulin resistance in hypertensive Type 1 (insulin-dependent) diabetic patients. Diabetologia 32, 523A (1989)
160. Mangili R, J. J. Bending, G. Scott, L. K. Li, A. Gupta, & G. Viberti: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N. Engl. J. Med. 318, 146-50 (1988)
161. Mead PA, R. Wilkinson, & T. H. Thomas: Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial. Diabetes Care. 24, 527-32 (2001)
162. Winocour PH, C. Catalano, T H. Thomas, R. Wilkinson, & K. G. Alberti: Increased red cell sodium lithium countertransport activity, total exchangeable sodium, and hormonal control of sodium balance in normoalbuminuric type 1 diabetes. Diabet Med. 10, 825-32 (1993)
163. Monciotti CG, A. Semplicini, A. Morocutti, M. Maioli, M. R. Cipollina, I. Barzon, C. Palaro, E. Brocco, M. Trevisan, P. Fioretto, G. Crepaldi, & R. Nosadini: Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Diabetologia 40, 654-61 (1997)
164. + countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care. 22, 1158-64 (1999)
165. Mangili R, G. Zerbini, C. Barlassina, D. Cusi, & G. Pozza: Sodium-lithium countertransport and triglycerides in diabetic nephropathy. Kidney Int. 44, 127-33 (1993)
166. Carr S, J. C. Mbanya, T. Thomas, P. Keavey, R. Taylor, K. G. Alberti, & R. Wilkinson: Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevate erythrocyte sodium-lithium countertransport. N. Engl. J. Med. 322, 500-5 (1990)
167. Lawson ML, E. B. Sochett, M. R. Frank, M. K. Fry, D. Stephens, P. Chait, & D. Daneman: Intensive diabetes management decreases Na-Li countertransport in young subjects with type 1 diabetes and enlarged kidneys. J Diabetes Complications. 14, 333-9 (2000)
168. Lopes de Faria JM, L. A. Silveira, M. Morgano, E. J. Pavin, & J. B. Lopes de Faria: Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 41, 1482-5 (2000)
169. Lever AF: Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J. Hypertension 4, 515-24 (1986)
170. Devereux, RB: Hypertensive cardiac hypertrophy. Pathophysiologic and clinical characteristics, in Hypertension: pathophysiology diagnosis and management, Laragh J. H. and BrennerB. M. eds, Raven Press, New York, 26, 359, 1990.
171. Grinstein S, D. Rotin, M. & J. Mason: Na/H exchange and growth factor - induced cytosolic pH changes. Role in cellular proliferation. Biochim. Biophys. Acta 988, 73-97 (1989)
172. Semplicini A, W. Siffert, M. Sartori, A. Monari, C. Naber, G. Frigo, M. Santonastaso, F. Cozzutti, M. Winnicki, & P. Palatini: G protein beta3 subunit gene 825T allele is associated with increased left ventricular mass in young subjects with mild hypertension. Am J Hypertens. 14, 1191-5 (2001)
173. Funder, J., Wieth, J. O., Jensen, H. A., & Ibsen, K. K., The sodium/lithium exchange mechanism in essential hypertension:is it a sodium/proton exchanger?, in Topics in pathophysiology of hypertension, H. Villareal M.P. Sambhi eds. Nijnhoff Boston, 147-156 (1984)
174. Aronson PS: Red-cell sodium-lithium countertransport and essential hypertension. N. Engl. J. Med. 307, 317 (1982)
175. Mahnensmith RL, & P. S. Aronson: The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ. Res. 56, 773-88 (1985)
176. Kahn AM, J. C. Allen, E. J. Cragoe, R. Zimmer, & H. Shelat: Sodium-lithium exchange in sarcolemmal vesicles from canine superior mesenteric artery. Circ. Res. 62, 478-85 (1988)
177. Kahn AM, J. C. Allen, E. J. Cragoe, & H. Shelat: Sodium-lithium exchange and sodium-proton exchange are mediated by the same transport system in sarcolemmal vesicles from bovine superior mesenteric artery. Circ. Res. 65, 818-28 (1989)
178. + exchange of rabbit red cells: evidence for a common pathway. J. Memb. Biol. 118, 193-214 (1990)
179. Canessa M, K. Morgan, & A. Semplicini: Genetic differences in lithium-sodium exchange and regulation of the sodium-hydrogen exchanger in essential hypertension. J. Cardiovasc. Pharmacol. 12, S92-8 (1988)
180. + exchange are mediated by the same membrane transport protein in human red blood cells: an NMR investigation. Biochemistry 24, 12433-42 (1996)
181. Canessa M, K. Morgan, R. Goldszer, T. J. Moore, & A. Spalvins: Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension 17, 340- (1991)
182. + exchange in hypertensive patients. J Hypertens. 13, 1566-70 (1995)
183. + exchanger isoforms in human proximal tubules. Kidney Int. 58, 229-35 (2000)
184. Busch S, B. C. Burckhardt, & W. Siffert: Expression of the human sodium/proton exchanger NHE-1 in Xenopus laevis oocytes enhances sodium/proton exchange activity and establishes sodium/lithium countertransport. Pflugers Arch 429, 859-69 (1995)
185. + exchanger. Am. J. Physiol. 272 (Cell Physiol, 41), C818-C826 (1997)
186. + fluxes in human red cells: amiloride sensitivity. J. Biol. Chem 260, 11914-23 (1985)
187. Lifton RP, S. C. Hunt, R. R. Williams, J. Pouyssegur,& J. M. Lalouel: Exclusion of the Na-H antiporter as a candidate gene in human essential hypertension. Hypertension 17, 8-14 (1991)
188. Sartori M, G. Ceolotto, & A. Semplicini: MAPKinase and regulation of the sodium-proton exchanger in human red blood cell. Biochim. Biophys. Acta. 21, 1421, 140-8 (1999)
189. + exchangers. Physiol. Rev. 77, 51-74 (1997)
190. Agam G, P. Hatzav, S. Abekasis, A. Loven, & A. Livne: Elevated intracellular Ca2+ affects Lii-Nao countertransport in human red blood cells. Biochim. Biophys. Acta 904, 207-15 (1987)
191. + exchanges modulates Ca++ mobilization in human platelets stimulated by ADP and the thromboxane mimetic U 46619. J. Biol. Chem. 264, 719-25 (1990)